Cite
Effect of symptom severity on efficacy and safety of aripiprazole adjunctive to antidepressant monotherapy in major depressive disorder: A pooled analysis.
MLA
Stewart, Thomas D., et al. “Effect of Symptom Severity on Efficacy and Safety of Aripiprazole Adjunctive to Antidepressant Monotherapy in Major Depressive Disorder: A Pooled Analysis.” Journal of Affective Disorders, vol. 162, June 2014, pp. 20–25. EBSCOhost, https://doi.org/10.1016/j.jad.2014.03.017.
APA
Stewart, T. D., Hatch, A., Largay, K., Sheehan, J. J., Marler, S. V., Berman, R. M., & Nelson, J. C. (2014). Effect of symptom severity on efficacy and safety of aripiprazole adjunctive to antidepressant monotherapy in major depressive disorder: A pooled analysis. Journal of Affective Disorders, 162, 20–25. https://doi.org/10.1016/j.jad.2014.03.017
Chicago
Stewart, Thomas D., Ainslie Hatch, Kimberly Largay, John J. Sheehan, Sabrina V. Marler, Robert M. Berman, and J. Craig Nelson. 2014. “Effect of Symptom Severity on Efficacy and Safety of Aripiprazole Adjunctive to Antidepressant Monotherapy in Major Depressive Disorder: A Pooled Analysis.” Journal of Affective Disorders 162 (June): 20–25. doi:10.1016/j.jad.2014.03.017.